FFilingSight

Not investment advice. FilingSight is an automated analytical research tool, not a registered investment advisor. Ratings and scores are quantitative analytical classifications, not buy or sell recommendations. Nothing here is personalized to your circumstances. Investing involves risk of loss — consult a licensed professional. See full disclosures.

Create a free account to read 3 full reports each month — plus a 14-day Pro trial. Get started →

Travelers Cos.

TRVFinancials

Generated Jul 6, 2026, 10:02 PM UTC

analytical score 9

TRV (Travelers Cos.) analytical snapshot. Revenue grew +5.2% YoY to $48.83B. 5-year revenue CAGR +7.0%; 10y CAGR +6.5%. Net margin at 12.88% (expanding ▲). Market cap $72.12B at $339.17 per share. Trailing P/E 12.36, P/S 1.48, P/B 2.25. EV/Operating income ≈ 21.25 (EV $77.37B). Risk: Moderate. Macro: Risk-on · Supportive. Composite analytical score 9 (data confidence 74%). Descriptive analytics from public filings — not investment advice.

Market cap
$72.12B
212.64M shares
Price
$339.17
NYQ
P/E (ttm)
12.36
Revenue (FY)
$48.83B
YoY +5.2%
Net margin
12.88%
▲ 5.17pp
Free cash flow
Risk level
Moderate

Free SEC analysis

— computed from SEC filings, free to read
Free previewRegulatory Analyst

Filings & Ownership

Regulatory Analyst
score -10Stable
80% conf

Latest annual report (10-K) filed Feb 12, 2026. Latest quarterly report (10-Q) filed Apr 16, 2026. 6 recent 8-K material-event filings in the index.

  • Latest annual report (10-K) filed Feb 12, 2026.
  • Latest quarterly report (10-Q) filed Apr 16, 2026.
  • 6 recent 8-K material-event filings in the index.
  • Recent insider Form 4s: 0 buy vs 5 sell transactions — net selling $6.5M.
  • ~10,000+ recent 13F-HR filings reference Travelers Cos.; broad institutional reporting.
  • Recent filers include Rosenbaum Jay D., Rosenbaum Jay D., Rosenbaum Jay D..
  • 20 recent 13G passive institutional ownership notices.
Latest 10-K
Feb 12, 2026
Annual report
Latest 10-Q
Apr 16, 2026
8-K (recent)
6
Insider net
-$6.5M
0B/5S
13F filers
10k+
Activist 13D
0
Recent 13F institutional filers (SEC EDGAR full-text)
FilerFormFiled
Rosenbaum Jay D.13F-HROct 26, 2021
Rosenbaum Jay D.13F-HRJul 14, 2021
Rosenbaum Jay D.13F-HRApr 26, 2021
Connolly Sarah T.13F-HRJul 14, 2021
Connolly Sarah T.13F-HRApr 26, 2021
Recent insider Form 4 activity
InsiderDateNetBuys/Sells
Klein Michael FrederickMay 27, 2026-$3.1M0/3
BESSETTE ANDY FMay 26, 2026-$1.3M0/1
Kess Avrohom J.Apr 29, 2026-$2.1M0/1
Recent 8-K material events
DateFormDescription
May 22, 20268-KFORM 8-K
May 21, 20268-KFORM 8-K
Apr 16, 20268-K8-K
Feb 17, 20268-KFORM 8-K
Feb 6, 20268-KFORM 8-K
Jan 21, 20268-K8-K
Insider Form 4 sentiment (transactions)
Buys: 0
Sells: 5
Buys
Sells
Free previewSEC Filing Analyst

SEC Filing Deep-Analysis

SEC Filing Analyst
score -50Deteriorating
62% conf

3 risk signal(s), 1 positive signal(s), 2 watch item(s) detected from XBRL filing diff analysis. 3 risk signal(s) detected versus 1 positive signal(s). The balance of evidence suggests elevated filing-specific risk that warrants monitoring in subsequent filings.

  • NEW: Going concern doubt in latest filing: The term "going concern" "substantial doubt" appears in recent 10-K/10-Q filings but was NOT present in the prior 24-month period. This is a new risk disclosure that warrants attention. Found in 4 filing(s).
  • NEW: Substantial doubt about ability to continue in latest filing: The term "substantial doubt" "ability to continue" appears in recent 10-K/10-Q filings but was NOT present in the prior 24-month period. This is a new risk disclosure that warrants attention. Found in 4 filing(s).
  • NEW: Restatement of financial statements in latest filing: The term "restatement of" "previously issued" appears in recent 10-K/10-Q filings but was NOT present in the prior 24-month period. This is a new risk disclosure that warrants attention. Found in 5 filing(s).
  • Operating cash flow exceeds net income: OCF is 1.69x net income, indicating high earnings quality — cash conversion is strong and accruals are not inflating reported profits.
  • NEW: Impairment charge: Impairment charge appears in recent filings but not in the prior 24-month period. Monitor for materiality.
  • NEW: Restructuring: Restructuring appears in recent filings but not in the prior 24-month period. Monitor for materiality.
  • Endogenous analysis: 3 risk signal(s) detected versus 1 positive signal(s). The balance of evidence suggests elevated filing-specific risk that warrants monitoring in subsequent filings.
  • 4 new XBRL disclosure(s) in latest filing — expanding reporting scope.
  • 20 disclosure(s) dropped from prior year — reduced reporting granularity.
  • 5 new risk-language term(s) detected in filing text: Going concern doubt, Substantial doubt about ability to continue, Restatement of financial statements, Impairment charge, Restructuring.
Revenue
$48.83B
+5.2% YoY
Operating income
$3.64B
+2.1% YoY
Net income
$6.29B
+25.8% YoY
Operating cash flow
$10.61B
+16.9% YoY
Total assets
$143.71B
+7.9% YoY
Total liabilities
$110.81B
+5.2% YoY
Long-term debt
$5.86B
-6.4% YoY
Cash & equivalents
$842.0M
+20.5% YoY
Filing quality score
73/100
4 new disclosures
SEC XBRL metric changes (latest annual vs prior)
MetricPrior yearLatest yearChange% Change
Revenue$46.42B$48.83B$2.40B+5.2%
Operating income$3.57B$3.64B$74.0M+2.1%
Net income$5.00B$6.29B$1.29B+25.8%
Operating cash flow$9.07B$10.61B$1.53B+16.9%
Total assets$133.19B$143.71B$10.52B+7.9%
Total liabilities$105.33B$110.81B$5.49B+5.2%
Long-term debt$6.26B$5.86B$-400.0M-6.4%
Cash & equivalents$699.0M$842.0M$143.0M+20.5%
Stockholders equity$27.86B$32.89B$5.03B+18.1%
SG&A expense$5.82B$6.12B$301.0M+5.2%
Interest expense$392.0M$425.0M$33.0M+8.4%
XBRL disclosure changes (new vs dropped concepts)
TypeConcepts
AddedAlternativeInvestment, DisposalGroupIncludingDiscontinuedOperationInvestment, InvestmentsFairValueDisclosure, ProceedsFromDivestitureOfBusinesses
RemovedAccruedIncomeTaxesCurrent, AmortizationOfIntangibleAssets, AssetsHeldByInsuranceRegulators, AssumedPremiumsEarned, AssumedPremiumsWritten, AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost, AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue, AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost, AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue, AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
Risk language in filing text (EDGAR full-text search)
TermSeverityRecentPriorStatus
Going concern doubthigh40NEW
Substantial doubt about ability to continuehigh40NEW
Restatement of financial statementshigh50NEW
Impairment chargemedium50NEW
Restructuringmedium50NEW
Off-balance sheet arrangementsmedium52Ongoing
Filing signal breakdown
Red flags: 3
Positive: 1
Watch: 2
Red flags
Positive
Watch
Free previewFundamentals Analyst

Fundamentals

Fundamentals Analyst
score 45Improving
60% conf

Revenue grew +5.2% YoY to $48.83B. 5-year revenue CAGR +7.0%; 10y CAGR +6.5%. Net margin at 12.88% (expanding ▲).

  • Revenue grew +5.2% YoY to $48.83B.
  • 5-year revenue CAGR +7.0%; 10y CAGR +6.5%.
  • Net margin at 12.88% (expanding ▲).
  • Return on equity 19.12%, ROA 4.38%, ROIC 0.00%.
  • Gross margin 0.00%, operating margin 0.00%.
  • Net income up ▲ +25.8% YoY.
  • Debt/equity 0.18, current ratio —, net debt $5.25B.
  • Asset turnover 0.34 — capital efficiency.
Revenue (FY)
$48.83B
YoY +5.2%
Net margin
12.88%
▲ 5.17pp
ROE
19.12%
ROA 4.38%
ROIC
0.00%
EPS (diluted)
$27.43
FY2025
Free cash flow
Debt / equity
0.18
Cash $615.0M
Current ratio
Equity $31.99B
Annual fundamentals — up to 10 years (SEC 10-K, US-GAAP)
FYRevenueRev YoYGross%Op%Net%FCFROE%
2024$46.42B+12.2%0.000.0010.7717.94
2025$48.83B+5.2%0.000.0012.8819.12
Quarterly revenue trend (last 6 quarters, SEC 10-Q)
Quarter endRevenueYoYQoQNet margin
Jun 30, 2024$11.28B+11.7%4.73%
Sep 30, 2024$11.90B+11.9%+5.5%10.58%
Mar 31, 2025$11.81B+5.2%-0.8%3.34%
Jun 30, 2025$12.12B+7.4%+2.6%12.45%
Sep 30, 2025$12.47B+4.8%+2.9%15.14%
Mar 31, 2026$11.92B+1.0%-4.4%14.35%
+8 more years of history, charts & full breakdown Pro

Pro analysis — preview

— score, signals & key metrics shown; full reasoning locked

Valuation

Valuation Analyst
score 0Stable
83% conf

Market cap $72.12B at $339.17 per share. Trailing P/E 12.36, P/S 1.48, P/B 2.25. EV/Operating income ≈ 21.25 (EV $77.37B).

  • Market cap $72.12B at $339.17 per share.
Market cap
$72.12B
212.64M shares
P/E (ttm)
12.36
P/S
1.48
P/B
2.25
EV
$77.37B
Intrinsic (DCF)
ProFull breakdown & reasoning locked

Price & Technicals

Technical Analyst
score 50Improving
85% conf

Price $339.17 — uptrend (above 200-DMA); 1-month momentum positive. RSI(14) 83.19 (overbought).

  • Price $339.17 — uptrend (above 200-DMA); 1-month momentum positive.
Price
$339.17
NYQ
RSI(14)
83.19
50-DMA
$306.50
200-DMA
$292.27
Volatility (ann.)
18.31%
52w range
$249.19–$343.45
-1.2% from high
ProFull breakdown & reasoning locked

Macro & Rates

Macro Analyst
score 15Stable
80% conf

Risk-on · Supportive. Real GDP growth 2.10% (quarterly, as of Jan 1, 2026). CPI inflation +4.2% YoY (above the Fed's long-run ~2% target). Fed funds rate 3.63%, 10Y Treasury 4.49%.

  • Market regime: Risk-on · Supportive.
GDP growth
2.10%
CPI (YoY)
+4.2%
Fed funds
3.63%
10Y yield
4.49%
10Y−2Y
0.35pp
Unemployment
4.20%
ProFull breakdown & reasoning locked

Risk Scorecard

Risk Analyst
score -6Stable
83% conf

Composite risk Moderate. Leverage debt/equity 0.18 (low). Earnings stability: net-margin stdev 2.70pp over 18y.

  • Composite risk: Moderate.
Risk level
Moderate
Debt / equity
0.18
Current ratio
Margin stdev
2.70pp
Cash / assets
0.43%
Liab / assets
77.52%
ProFull breakdown & reasoning locked

See the full picture behind every stock

Unlock the complete 10-year fundamentals, DCF & Graham intrinsic value, 13F/13D ownership flow, risk scorecard, multi-analyst bull/bear debate — plus watchlist alerts and your research workspace. Start with a 14-day Pro trial.

3 sections free · 4 Pro previews · composite 9

Macro exposure

Rate-sensitive · High sensitivity
Neutral

Macro regime: Risk-on · Supportive. Travelers Cos. is a rate-sensitive name (high macro sensitivity) — a supportive backdrop, though defensives lag risk-on tapes.

Macro regime
Risk-on · Supportive
Yield curve
Normal
VIX
15.81
Fed funds
3.63%
CPI YoY
+4.2%

Analytical read

deterministic preview

Revenue grew **+5.2%** YoY to $48.83B..

Risk
Moderate
Macro regime
Risk-on · Supportive
Macro exposure
Neutral
Descriptive analytics from public filings and macro data — not investment advice.

Peer comparison

Rate-sensitive group

How TRV stacks up against tracked peers with similar macro sensitivity — by analytical score and macro exposure.

CompanyScoreMacro
Allstate Corp. ALL30Neutral
Capital One Financial COF23Neutral
Chubb Ltd. CB20Neutral
American Express Co. AXP16Neutral
U.S. Bancorp USB14Neutral
Simon Property Group SPG13Neutral
Dominion Energy D12Neutral
Travelers Cos. TRV● you9Neutral
Mastercard Inc. MA8Neutral
Visa Inc. V7Neutral
Charles Schwab Corp. SCHW6Neutral
CME Group Inc. CME6Neutral
JPMorgan Chase & Co. JPM6Neutral
PNC Financial Services PNC5Neutral
Moody's Corp. MCO5Neutral
Wells Fargo & Co. WFC5Neutral
Citigroup Inc. C3Neutral
Exelon Corp. EXC3Neutral
Realty Income Corp. O3Neutral
Duke Energy Corp. DUK2Neutral
Bank of America Corp. BAC2Neutral
American International Group AIG1Neutral
Bank of New York Mellon BK0Neutral
Marsh & McLennan MMC0Neutral
Equity Residential EQR0Neutral
Public Storage PSA-1Neutral
Welltower Inc. WELL-1Neutral
NextEra Energy NEE-2Neutral
Morgan Stanley MS-2Neutral
Prologis Inc. PLD-3Neutral
Digital Realty Trust DLR-4Neutral
Xcel Energy XEL-5Neutral
Truist Financial TFC-5Neutral
American Water Works AWK-9Neutral
Goldman Sachs Group GS-10Neutral
S&P Global SPGI-10Neutral
MetLife Inc. MET-13Neutral
BlackRock Inc. BLK-14Neutral
Southern Company SO-15Neutral
Equinix Inc. EQIX-16Neutral
American Electric Power AEP-18Neutral
Crown Castle Inc. CCI-19Neutral
American Tower Corp. AMT-39Neutral